Trulicity, Byetta, Victoza, Similar Diabetes Drugs Do Not Appear to Increase Breast Cancer Risks: Study
A new study finds no link between popular diabetes drugs like Byetta and Trulicity, and an increased risk of breast cancer.
A new study finds no link between popular diabetes drugs like Byetta and Trulicity, and an increased risk of breast cancer.
The first bellwether trials for reinstated Byetta, Victoza, pancreatitis lawsuits are not likely to begin before late 2020.
An Illinois appeals court has reinstated two Januvia lawsuits, saying that juries must decide failure to warn claims over pancreatic cancer risks.
Side effects of Byetta, Victoza, Januvia and other diabetes drugs may increase risk of pancreatic cancer.
A proposed combination of Victoza and Tresiba is raising concerns among FDA reviewers who are worried that the low doses may expose patients to Victoza side effects without providing actual…
A federal judge has granted summary judgment in the federal litigation over incretin mimetic diabetes drugs, which alleged that inadequate warnings were provided about the risk of pancreatic cancer from…
The FDA is warning that Januvia and similar diabetes drugs may be causing cases of severe joint pain among users.
A new study shows significant weight loss through Victoza use but warns of increased risk of gastrointestinal disorders.
Doctors should individualize diabetes drug treatments for patients with a high risk of heart disease, due to the varying levels of cardiovascular risk associated with certain diabetes drugs, according to…
A federal judge has been asked to enter summary judgement in failure to warn lawsuits filed over the pancreatic cancer risk with Byetta, Januvia, Janumet and Victoza, arguing that the…